A study by J. Correale et al. provided evidence that smoking in patients with MS leads to increased production of IL-13 and IL-6, which has been associated with reduced indoleamine 2,3-dioxygenase (IDO) activity [56,66,67]. This evidence concerns the gene IL6 and myeloid sarcoma.